Company: FVN
Filing Date: 2025-01-07
Form Type: DRS/A
Source: 0001829126-25-000092
Chunk: 511

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-01-07
Form: DRS/A
Chunk 511
---
 used.

Use of Estimates

The preparation of financial
statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets
and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts
of expenses during the reporting period.

Making estimates requires
management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation
or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate,
could change in the near term due to one or more future confirming events. Actual results could differ from these estimates.

Cash and cash equivalents

The Company considers all
highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. The Company did not
have any cash equivalents.

Deferred Offering Costs

The Company complies with
the requirements of ASC 340-10-S99-1 and SEC Staff Accounting Bulletin (“SAB”) Topic 5A — Expenses of Offering.
Deferred offering costs consist of underwriting, legal, accounting and other expenses incurred through the balance sheet date that are
directly related to the Proposed Public Offering and that will be charged to shareholder’s equity upon the completion of the Proposed
Public Offering. Should the Proposed Public Offering prove to be unsuccessful, these deferred costs, as well as additional expenses to
be incurred, will be charged to operations.

Fair Value of Financial Instruments

The fair value of the Company’s
assets and liabilities, which qualify as financial instruments under FASB ASC 820, “Fair Value Measurements and Disclosures,”
approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature. The carrying
amounts reported in the balance sheet for cash and cash equivalents and promissory note - related party each qualify as financial instruments
and are a reasonable estimate of their fair values because of the short period between the origination of such instruments and their
expected realization and their current market rate of interest.

Concentration of Credit Risk

Financial instruments that
potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution which, at times
may exceed the Federal depository insurance coverage of $250,000. The Company has not experienced losses on this account and management
believes the Company is not exposed to significant risks on such account.

<div align='center'>F-28</div>

Ordinary shares subject to possible redemption